Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Phase 1a/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis.
Epistemonikos ID: ad7ac32a6d729662195114aea3dcef976a58d17a
First added on: Oct 15, 2026